Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective

Synergy is a process in which some substances cooperate to reach a combined effect that is greater than the sum of their separate effects. It can be considered a natural “straight” strategy which has evolved by nature to obtain more efficacy at low cost. In this regard, synergistic effects may be observed in the interaction between herbal products and conventional drugs or biochemical compounds. It is important to identify and exploit these interactions since any improvement brought by such kind of process can be advantageously used to treat human disorders. Even in a complex disease such as cancer, positive synergistic plant–drug interactions should be investigated to achieve the best outcomes, including providing a greater benefit to patients or avoiding adverse side effects. This review analyzes and summarizes the current knowledge on the synergistic effects of plant–drug interactions with a focus on anticancer strategies.

[1]  B. Salehi,et al.  The therapeutic potential of curcumin: A review of clinical trials. , 2019, European journal of medicinal chemistry.

[2]  B. Salehi,et al.  Nepeta species: From farm to food applications and phytotherapy , 2018, Trends in Food Science & Technology.

[3]  A. Mishra,et al.  Resveratrol: A Double-Edged Sword in Health Benefits , 2018, Biomedicines.

[4]  B. Salehi,et al.  Phytochemicals in Helicobacter pylori Infections: What Are We Doing Now? , 2018, International journal of molecular sciences.

[5]  B. Salehi,et al.  Ethnobotany of the genus Taraxacum—Phytochemicals and antimicrobial activity , 2018, Phytotherapy research : PTR.

[6]  B. Salehi,et al.  Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion , 2018, Molecules.

[7]  A. Mishra,et al.  Satyrium nepalense, a high altitude medicinal orchid of Indian Himalayan region: chemical profile and biological activities of tuber extracts. , 2018, Cellular and molecular biology.

[8]  B. Salehi,et al.  Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy , 2017, Molecules.

[9]  Ziyu Jiang,et al.  β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[10]  A. Ramos-Esquivel,et al.  Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance. , 2017, Journal of oncology practice.

[11]  L. Skálová,et al.  The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines , 2017, Molecules.

[12]  Ray-Jade Chen,et al.  Inhibition of NF‐κB and metastasis in irinotecan (CPT‐11)‐resistant LoVo colon cancer cells by thymoquinone via JNK and p38 , 2017, Environmental toxicology.

[13]  E. M. Williamson,et al.  A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies , 2016, Phytotherapy research : PTR.

[14]  Weidong Chen,et al.  Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. , 2016, European journal of pharmacology.

[15]  Rana Khalife,et al.  Thymoquinone from Nigella sativa Seeds Promotes the Antitumor Activity of Noncytotoxic Doses of Topotecan in Human Colorectal Cancer Cells in Vitro , 2016, Planta Medica.

[16]  A. Mileo,et al.  Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies , 2015, Oxidative medicine and cellular longevity.

[17]  Lena Jaeger,et al.  Concise Dictionary Of Modern Medicine , 2016 .

[18]  Banu Iskender,et al.  The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer , 2016, Tumor Biology.

[19]  M. Wink,et al.  Cytotoxic potentiation of vinblastine and paclitaxel by L-canavanine in human cervical cancer and hepatocellular carcinoma cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[20]  G. D'andrea Quercetin: A flavonol with multifaceted therapeutic applications? , 2015, Fitoterapia.

[21]  Solomon Habtemariam,et al.  Genistein and cancer: current status, challenges, and future directions. , 2015, Advances in nutrition.

[22]  Mou-Ze Liu,et al.  Pharmacogenomics and Herb-Drug Interactions: Merge of Future and Tradition , 2015, Evidence-based complementary and alternative medicine : eCAM.

[23]  W. Kuo,et al.  Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38. , 2015, Journal of agricultural and food chemistry.

[24]  Yan Ding,et al.  Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. , 2015, International journal of clinical and experimental pathology.

[25]  E. Bozkurt,et al.  Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway , 2015, Clinical and Translational Oncology.

[26]  E. Williamson,et al.  Cancer Patients at Risk of Herb/Food Supplement–Drug Interactions: A Systematic Review , 2014, Phytotherapy research : PTR.

[27]  U. Kadam,et al.  Multi-drug therapy in chronic condition multimorbidity: a systematic review. , 2014, Family practice.

[28]  Rana Khalife,et al.  The anti-proliferative and pro-apoptotic effect of topotecan in combination with thymoquinone in acute myelogenous leukemia , 2014 .

[29]  A. Kourounakis,et al.  Multi-target drug design approaches for multifactorial diseases: from neurodegenerative to cardiovascular applications. , 2014, Current medicinal chemistry.

[30]  A. Mantha,et al.  Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View , 2014, BioMed research international.

[31]  Chi-Ying F. Huang,et al.  Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs. , 2014, The Journal of nutritional biochemistry.

[32]  Jun Yu,et al.  Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer , 2014, Integrative cancer therapies.

[33]  D. Hoskin,et al.  Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53 , 2014, Nutrition and cancer.

[34]  M. Kamal,et al.  Hepatoprotective Effects of Silybum marianum (Silymarin) and Glycyrrhiza glabra (Glycyrrhizin) in Combination: A Possible Synergy , 2014, Evidence-based complementary and alternative medicine : eCAM.

[35]  P. Fasinu,et al.  Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges. , 2014, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[36]  Yan Ma,et al.  Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer☆ , 2013, Current therapeutic research, clinical and experimental.

[37]  E. Kennelly,et al.  Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric. , 2013, Anti-cancer agents in medicinal chemistry.

[38]  Marco Pautasso,et al.  Ten Simple Rules for Writing a Literature Review , 2013, PLoS Comput. Biol..

[39]  H. Tokuda,et al.  Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines , 2013, Journal of complementary & integrative medicine.

[40]  S. Usha,et al.  An ex vivo study of selenium, genistein on the morphological and nuclear changes in anticancer drug-induced apoptosis in human peripheral blood lymphocytes. , 2013, BioFactors.

[41]  M. R. Bailey,et al.  Ginkgo biloba: indications, mechanisms, and safety. , 2013, The Psychiatric clinics of North America.

[42]  Jinshun Zhao,et al.  β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells. , 2013, Anticancer research.

[43]  G. Eumkeb,et al.  Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant Enterobacter cloacae. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[44]  Wei Zhang,et al.  Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-κB/IKK Pathway-Induced Apoptosis , 2013, PloS one.

[45]  V. Butterweck,et al.  Pharmacokinetic Evaluation of Visnagin and Ammi visnaga Aqueous Extract after Oral Administration in Rats , 2012, Planta Medica.

[46]  D. H. Sweet,et al.  Competitive inhibition of human organic anion transporters 1 (SLC22A6), 3 (SLC22A8) and 4 (SLC22A11) by major components of the medicinal herb Salvia miltiorrhiza (Danshen). , 2013, Drug metabolism and pharmacokinetics.

[47]  A. McLachlan,et al.  Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion–Transporting Polypeptides , 2012, Clinical pharmacology and therapeutics.

[48]  Jing-Rong Wang,et al.  Inhibition of P-Glycoprotein Leads to Improved Oral Bioavailability of Compound K, an Anticancer Metabolite of Red Ginseng Extract Produced by Gut Microflora , 2012, Drug Metabolism and Disposition.

[49]  C. Sharma,et al.  Concurrent Sulforaphane and Eugenol Induces Differential Effects on Human Cervical Cancer Cells , 2012, Integrative cancer therapies.

[50]  O. Obodozie Pharmacokinetics and Drug Interactions of Herbal Medicines: A Missing Critical Step in the Phytomedicine/Drug Development Process , 2012 .

[51]  Shwu-Huey Liu,et al.  Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. , 2012, Journal of ethnopharmacology.

[52]  G. Subramaniam,et al.  Assessment of Extracts from Red Yeast Rice for Herb-Drug Interaction by in-vitro and in-vivo assays , 2012, Scientific Reports.

[53]  K. Gough,et al.  A Potential Drug–Herbal Interaction between Ginkgo biloba and Efavirenz , 2012, Journal of the International Association of Physicians in AIDS Care.

[54]  A. Izzo Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data , 2012, Medical Principles and Practice.

[55]  B. Petrovska,et al.  Historical review of medicinal plants’ usage , 2012, Pharmacognosy reviews.

[56]  Xi-jun Wang,et al.  An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents. , 2011, Fitoterapia.

[57]  R. Roby,et al.  Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer. , 2011, Biochemical pharmacology.

[58]  Chun-song Zheng,et al.  Potential synergistic and multitarget effect of herbal pair Chuanxiong Rhizome-Paeonia Albifora Pall on osteoarthritis disease: A computational pharmacology approach , 2011, Chinese journal of integrative medicine.

[59]  I. So,et al.  Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. , 2011, Biochemical and biophysical research communications.

[60]  R. Schobert,et al.  Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin , 2011, Cancer Chemotherapy and Pharmacology.

[61]  H. Glaeser,et al.  Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. , 2010, Biochemical pharmacology.

[62]  S. M. Asdaq,et al.  Potential of garlic and its active constituent, S-allyl cysteine, as antihypertensive and cardioprotective in presence of captopril. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[63]  W. Rzeski,et al.  Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line. , 2010, Chemico-biological interactions.

[64]  O. Obodozie,et al.  The influence of Nifadin®, Niprisan® and Niprd/92/001/1-1 (AM-1) on the pharmacokinetics of metronidazole in rats , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[65]  Gangjun Du,et al.  Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. , 2010, International immunopharmacology.

[66]  P. van Bladeren,et al.  Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect. , 2010, Toxicology and applied pharmacology.

[67]  A. Demiroglu-Zergeroglu,et al.  The Investigation of Effects of Quercetin and Its Combination with Cisplatin on Malignant Mesothelioma Cells In Vitro , 2010, Journal of biomedicine & biotechnology.

[68]  T. S. Kim,et al.  Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. , 2010, Biochemical and biophysical research communications.

[69]  Y. Sawada,et al.  Inhibitory effects of herbal extracts on breast cancer resistance protein (BCRP) and structure-inhibitory potency relationship of isoflavonoids. , 2010, Drug metabolism and pharmacokinetics.

[70]  Barbara Bloom,et al.  Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. , 2009, National health statistics reports.

[71]  M. Maracy,et al.  Combined therapy of silymarin and desferrioxamine in patients with β‐thalassemia major: a randomized double‐blind clinical trial , 2009, Fundamental & clinical pharmacology.

[72]  Yu-Tang Tung,et al.  Protective effect of Acacia confusa bark extract and its active compound gallic acid against carbon tetrachloride-induced chronic liver injury in rats. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[73]  A. Bishayee,et al.  d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis , 2009, Journal of carcinogenesis.

[74]  Lawrence X. Yu,et al.  Mechanistic Approaches to Predicting Oral Drug Absorption , 2009, The AAPS Journal.

[75]  E. Ragazzi,et al.  Cell‐cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells , 2009, Cell proliferation.

[76]  M. Doble,et al.  Synergism between natural products and antibiotics against infectious diseases. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[77]  Hiroshi Suzuki,et al.  Inhibitory Effects of Terpenoids on Multidrug Resistance-Associated Protein 2- and Breast Cancer Resistance Protein-Mediated Transport , 2008, Drug Metabolism and Disposition.

[78]  A. Pichette,et al.  Potentiating effect of β‐caryophyllene on anticancer activity of α‐humulene, isocaryophyllene and paclitaxel , 2007 .

[79]  A. Rosato,et al.  Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[80]  A. Doria,et al.  Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing’s sarcoma cell lines , 2007, Journal of neurochemistry.

[81]  D. Brann,et al.  Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors , 2007, Journal of neurochemistry.

[82]  B. Aggarwal,et al.  Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. , 2007, Blood.

[83]  A. Pichette,et al.  Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel. , 2007, The Journal of pharmacy and pharmacology.

[84]  P. Imming,et al.  Drugs, their targets and the nature and number of drug targets , 2006, Nature Reviews Drug Discovery.

[85]  Sanjeev Banerjee,et al.  Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts , 2006, Cancer.

[86]  George D Geromichalos,et al.  Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro. , 2006, Cancer letters.

[87]  Liping Jiang,et al.  Synergistic Inhibitory Effects of Curcumin and 5-Fluorouracil on the Growth of the Human Colon Cancer Cell Line HT-29 , 2005, Chemotherapy.

[88]  Sanjeev Banerjee,et al.  Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice , 2005, Clinical Cancer Research.

[89]  Zhiwei Wang,et al.  Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. , 2005, Cancer research.

[90]  J. Grutsch,et al.  The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care , 2005, Supportive Care in Cancer.

[91]  R. Day,et al.  Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2005, British journal of clinical pharmacology.

[92]  W. Jonas Mosby's dictionary of complementary & alternative medicine , 2005 .

[93]  Shufeng Zhou,et al.  Pharmacokinetic Interactions of Drugs with St John’s Wort , 2004, Journal of psychopharmacology.

[94]  Andreas Rolfs,et al.  The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins , 2004, Pflügers Archiv.

[95]  Benjamin J. Whalley,et al.  Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects? , 2003 .

[96]  Min Huang,et al.  Interactions of Herbs with Cytochrome P450 , 2003, Drug metabolism reviews.

[97]  Takao Yokota,et al.  Plant foods and herbal sources of resveratrol. , 2002, Journal of agricultural and food chemistry.

[98]  Samir K. Gupta,et al.  Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not Desloratadine , 2002, Clinical pharmacokinetics.

[99]  Cody Schrank,et al.  American Cancer Society , 2005 .

[100]  K. Lundstrom,et al.  Neurochemical studies with St. John's wort in vitro. , 2001, Pharmacopsychiatry.

[101]  P. Chyka,et al.  Interactions of Warfarin with Garlic, Ginger, Ginkgo, or Ginseng: Nature of the Evidence , 2000, The Annals of pharmacotherapy.

[102]  J. Wang,et al.  Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. , 2000 .

[103]  A. Nahrstedt,et al.  Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.

[104]  Berenbaum Mc What is synergy? , 1989, Pharmacological reviews.

[105]  M. Berenbaum What is synergy? , 1989, Pharmacological reviews.

[106]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.

[107]  M C Berenbaum,et al.  Criteria for analyzing interactions between biologically active agents. , 1981, Advances in cancer research.

[108]  M C Berenbaum,et al.  Synergy, additivism and antagonism in immunosuppression. A critical review. , 1977, Clinical and experimental immunology.

[109]  R. Fuller,et al.  Operating Manual for Spaceship Earth , 1969 .

[110]  John Leyden. Webb,et al.  Enzyme and metabolic inhibitors , 1963 .

[111]  S. Loewe The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.